Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
rray
, 27 April, 2023
Recommendations for pt eval
By
rray
, 27 April, 2023
Yervoy ipilimumab
By
rray
, 27 April, 2023
Tecentriq atezolizumab
By
rray
, 27 April, 2023
Opdualag nivolumab relatlimab
By
rray
, 27 April, 2023
Opdivo nivolumab
By
rray
, 27 April, 2023
Libtayo cemiplimab
By
rray
, 27 April, 2023
Keytruda pembrolizumab
By
rray
, 27 April, 2023
Jemperli dostarlimab
By
rray
, 27 April, 2023
Imjudo tremelimumab
By
rray
, 27 April, 2023
Imfinzi durvalumab
Pagination
First page
Previous page
…
Page
374
Page
375
Page
376
Page
377
Current page
378
Page
379
Page
380
Page
381
Page
382
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube